Latest Content

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Jorgen Vestbo, MD, on the COPERNICOS trial results, long-term antibiotic use versus resistance concerns, and where COPD treatment is headed.

This new study from the VHA also shows neither cytoreductive therapy nor phlebotomy clearly lowers thrombosis risk.

New Harris Poll data show mental health, access, and postpartum care gaps persist for US mothers, with Black and Hispanic women hit hardest.

Despite financial incentives for Medicare Advantage (MA) plans to reduce potentially inappropriate medication use post hospitalization, this study found that MA does not provide a clear advantage over traditional Medicare.

GLP-1 prescribing among children aged 8 to 11 years with obesity rose 310-fold from 2019 to 2026, but use remains rare and unevenly distributed by income.

For Medicare Advantage beneficiaries, high out-of-pocket medical costs are associated with lower odds of medication adherence.

Francesca Puggioni, MD, discusses real-world exacerbations, biomarker-driven access, and barriers to earlier biologic use in asthma and COPD.

NCCN survey finds universal, persistent generic drug shortages; coping tactics stretch teams as looming tariffs threaten more supply disruptions.